Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Heparin (acute stroke)

Action
Intravenous anticoagulant.

Status
Heparin is widely used in acute stroke, but no randomized clinical trials support this use.

Trial(s)
  = Ongoing
  = Completed

AIST Acute Ischemic Stroke Trial - Oral Aspirin vs Intravenous Heparin on Stroke Progression
AUST Australian Urokinase Stroke Trial
CADISS Cervical Artery Dissection In Stroke Study: Feasibility Phase.
Early heparin therapy in patients with spontaneous intracerebral hemorrhage
Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.
Heparin treatment in sinus venous thrombosis
High-Dose IV Unfractionated Heparin vs. Aspirin in Acute Ischemic Stroke
Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke.
IST International Stroke Trial
Oral Aspirin vs. Intravenous Heparin for Acute Ischemic Stroke Progression
PREVAIL PREvention of VTE after Acute Ischemic Stroke with LMWH or Enoxaparin.
Randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks
Randomized trial of immediate anticoagulation of embolic stroke
RAPID Rapid Anticoagulation Prevents Ischemic Damage
Safety and Efficacy of Low-dose Heparin During Intracranial Angioplasty and Stent Placement

Web Links and Publications
Heparin Patient Information (MEDLINEplus).

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (Cochrane Review).
Cochrane Database Syst Rev. 2001;4:CD000119.

Oral Aspirin vs. Intravenous Heparin for Acute Ischemic Stroke Progression. XVII World Congress of Neurology.
JNS Volume 187, Supplement 1, page S258, June 2001.

Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack.
Cochrane Database Syst Rev 2000;(2):CD000248

A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.
Age Ageing 1994 Nov;23(6):512-6.

Heparin treatment in sinus venous thrombosis.
Lancet 1991 Sep 7;338(8767):597-600.

Early heparin therapy in patients with spontaneous intracerebral haemorrhage.
J Neurol Neurosurg Psychiatry 1991 May;54(5):466-7.

A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study.
Stroke 1989 Apr;20(4):441-7.

Intravenous heparin for the prevention of stroke progression in acute partial stable stroke.
Ann Intern Med 1986 Dec;105(6):825-8.

Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.
Stroke 1983 Sep-Oct;14(5):668-76.

UID: 25

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009